Label: CHLORURE DE POTASSIUM PROAMP- potassium chloride injection, solution, concentrate

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Unapproved drug for use in drug shortage

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated August 13, 2018

If you are a consumer or patient please visit this version.

  • HEALTH CARE PROVIDER LETTER

    La Jolla
    Pharmaceutical

    AGUETTANT
    ESSENTIAL
    MEDICINES

    Important Prescribing Information

    Subject: Temporary importation of Potassium Chloride Proamp® 0.15 g/mL (equivalent to 2 mEq/mL), concentrate for solution for infusion to address drug shortage

    June, 2018

    Dear Healthcare Professional,

    Due to the critical shortage of Potassium Chloride for Injection Concentrate 2 mEq/mL, USP in the United States (U.S.) market, Laboratoire Aguettant (Aguettant) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of Potassium Chloride for Injection. Aguettant has initiated temporary importation of its Potassium Chloride Proamp® 0.15 g/mL (equivalent to 2 mEq/mL) concentrate for solution for infusion. This product is manufactured and marketed in France by Aguettant.

    Given the scale of this shortage, FDA is coordinating with several firms to import Potassium Chloride for Injection 2 mEq/mL. At this time, however, no other entity except La Jolla Pharmaceutical Company is authorized by the FDA to import or distribute Aguettant's Potassium Chloride Proamp® 0.15 g/mL (equivalent to 2 mEq/mL) concentrate for solution for infusion. FDA has not approved Aguettant's Potassium Chloride Proamp® 0.15 g/mL concentrate for solution for infusion, but allows its temporary importation into the United States. You may be provided with additional letters for other imported products you receive. Please read each letter in its entirety because each letter may contain different, product-specific information.

    Effective immediately, and during this temporary period, Aguettant will offer the following presentation of Potassium Chloride for Injection:

    Product name and descriptionSizePack factorNDC Number
    Potassium Chloride Proamp® 0.15 g/mL, concentrate for solution for infusion (equivalent to 2 mEq/mL)10 mL50 ampules per box60710-015-50

    There are key differences between the labeling of the FDA approved Potassium Chloride for Injection 2 mEq/mL products and Aguettant's imported Potassium Chloride Proamp® 0.15 g/mL.

    It is important to note the following:

    • Aguettant's product is labeled Potassium Chloride Proamp® 0,15 g/mL which means 0.15 g/mL in the U.S. and is equal to 2 mEq/mL of potassium chloride. We have affixed the following sticker with this information on the carton for the imported product.
      Figure
    • The ampule label of Aguettant's product is in French without English translation. However, the carton and the prescribing information for Aguettant's product is translated into English. Institutions should develop a strategy, which may include labeling the ampules with key information, to ensure safe use of the product.
    • Aguettant's product does not contain a barcode. Institutions should manually input the product into their systems. Alternative procedures should be followed to assure that the correct drug product is being used and administered to individual patients.
    • Inspect the solution visually for particulate matter and discoloration prior to administration.
    • The imported product is packaged in polypropylene 10 mL ampules. To use the ampule, hold it upright, twist off the cap, and withdraw the solution using a syringe.

    A side by side comparison of the key differences in the labeling between the FDA-approved product and the imported product is displayed in the product comparison table at the end of this letter.

    Please refer to the package insert for the FDA-approved Potassium Chloride for Injection Concentrate, USP drug product for full prescribing information.

    To order or if you have questions about Aguettant's Potassium Chloride Proamp® 0.15 g/mL ampules, please contact La Jolla Pharmaceutical Company at 1-800-651-3861.

    To report an adverse event concerning the imported Potassium Chloride Proamp® 0.15 g/mL ampules, please contact La Jolla Pharmaceutical Company at 1-800-651-3861. Adverse events or quality problems experienced with the use of the Potassium Chloride Proamp® 0.15 g/mL ampules may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:

    • Complete and submit the report Online: www.fda.gov/medwatch/report.htm
    • Regular mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

    If you have any questions about the information contained in this letter or use of Aguettant's Potassium Chloride Proamp® 0.15 g/mL ampules, please contact La Jolla's Medical Information Contact Center (MICC) at 1-800-651-3861.

    Sincerely,

    Jérôme JOLY
    Laboratoire Aguettant
    Director, Global QP
    Cécile BAILLY
    Laboratoire Aguettant
    Medical Director
    George F. Tidmarsh, MD, PhD
    Chief Executive Officer
    La Jolla Pharmaceutical Company
    Doranne Frano
    Vice President, Regulatory Affairs
    La Jolla Pharmaceutical Company

    PRODUCT COMPARISON TABLE

    Import ProductU.S. Marketed Product
    AGUETTANTHOSPIRA
    PresentationFigureFigure
    Drug NamePotassium chloride Proamp® 0.15 g/mL, concentrate for solution for infusionPotassium Chloride for Injection Concentrate, USP
    Active Ingredient ConcentrationPotassium: 2.012 mmol/mL
    Equivalent to: (2 mEq K+/mL)
    (149 mg/mL)
    Each mL contains potassium chloride, 2 mEq (149 mg)
    Unit Volume / Volume10 ml polypropylene ampules
    The ampules are made by polypropylene compliant to the 3.1.6. European pharmacopoeia monograph.
    They are formed through blow fill seal process and are terminally sterilized at 121°C, assuring a maximal level of sterility of the contained solution.
    5 mL single dose vials
    Semi-rigid plastic vials fabricated from a specially formulated polyolefin.
    Indication and UsageConcentrate for solution for infusion administered to patients suffering from low potassium blood levels (hypokalemia). Potassium is naturally present in body fluids and is needed for normal body function. It can also be used as a potassium supply for patients who are unable to be fed orally and receive total parenteral nutrition.Potassium Chloride for Injection Concentrate, USP is indicated in the treatment of potassium deficiency states when oral replacement is not feasible.
  • PRINCIPAL DISPLAY PANEL - 10 mL Ampule Label

    POTASSIUM chlorure PROAMP®
    1,5 g - 10 mL
    0,15 g/mL
    2,012 mmol/mL d'ion K+
    Solution à diluer pour perfusion - IV
    A diluer avant utilisation

    K

    15%

    PRINCIPAL DISPLAY PANEL - 10 mL Ampule Label
  • PRINCIPAL DISPLAY PANEL - 10 mL Ampule Box

    CHLORURE DE POTASSIUM PROAMP® 0, 15 g/mL AGUETTANT
    POTASSIUM CHLORIDE

    CAUTION

    Potassium Chloride for Injection
    Concentrate

    Each ampule contains 20 mEq/10 mL
    (2 mEq/mL)

    0,15 g/mL = 2 mEq/mL

    Must be diluted before use

    IV use

    AGUETTANT

    50
    polypropylene ampoules

    1,5 g
    10 mL

    PRINCIPAL DISPLAY PANEL - 10 mL Ampule Box
  • INGREDIENTS AND APPEARANCE
    CHLORURE DE POTASSIUM PROAMP 
    potassium chloride injection, solution, concentrate
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:60710-015
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    potassium chloride (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152) potassium chloride0.15 g  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:60710-015-5050 in 1 BOX07/31/2018
    110 mL in 1 AMPULE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Unapproved drug for use in drug shortage07/31/2018
    Labeler - Laboratoire Aguettant (267584998)
    Establishment
    NameAddressID/FEIBusiness Operations
    Laboratoire Aguettant271085545MANUFACTURE(60710-015) , ANALYSIS(60710-015) , LABEL(60710-015) , PACK(60710-015) , STERILIZE(60710-015) , RELABEL(60710-015)